Skip to main content

Table 4 Diagnostic performance of CT based on the clinical significance (per-patient analysis)

From: Whole-body low-dose CT can be of value in prostate cancer decision-making: a retrospective study on 601 patients

Expertise

Sensitivity% (95% CI)

Specificity% (95% CI)

NPV% (95% CI)

PPV% (95% CI)

Accuracy% (95% CI)

TP

TN

FP

FN

(a) Evaluation based on CHAARTED (Initial staging)

Junior radiologist

63.6 (49.6–76.2)

98.1 (94.5–99.6)

88.4 (84.4–91.6)

92.1 (78.9–97.3)

88.6 (83.6–92.6)

35

153

3

20

Nuclear medicine

60.3 (46.6–73.0)

98.7 (95.3–99.7)

86.8 (82.7–90.0)

94.6 (81.3–98.6)

87.7 (82.5–91.8)

35

151

2

23

Senior radiologist

71.2 (56.9–82.9)

99.4 (96.6–100)

91.3 (87.3–94.2)

97.4 (83.9–99.6)

92.4 (88.0–95.6)

37

158

1

15

(b) Evaluation based on LATITUDE (Initial staging)

Junior radiologist

67.2 (53.7–79.0)

98.7 (95.4–99.8)

88.8 (85.0–92.0)

95.1 (83.0–98.7)

90.1 (85.2–93.7)

39

151

2

19

Nuclear medicine

62.3 (49.0–74.4)

98.7 (95.3–99.8)

86.6 (82.3–89.9)

95 (82.6–98.7)

88.2 (82.3–89.9)

38

148

2

23

Senior radiologist

76.4 (63.0–86.8)

99.4 (96.5–100)

92.3 (88.1–95.0)

97.7 (85.6–99.7)

93.4 (89.1–96.3)

42

155

1

13

(c) Osteo-metastasis evaluation in biochemical recurrent patients

Junior radiologist

72.9 (62.9–81.5)

95.9 (93.0–97.9)

91.6 (88.6–93.8)

85.4 (78.8–91.1)

90.3 (86.9–93.0)

70

282

12

26

Nuclear medicine

70.4 (60.3–79.2)

98.6 (96.5–99.6)

90.9 (88.0–93.1)

94.5 (86.6–97.9)

91.5 (88.3–94.1)

69

288

4

29

Senior radiologist

81.3 (71.8–88.7)

98.3 (96.1–99.5)

94.4 (91.8–96.4)

93.7 (86.1–97.3)

94.4 (91.6–96.4)

74

294

5

17

  1. CI confidence interval, TP true positive, TN true negative, FP, false positive, FN false negative